Microalgae, a Potential Natural Functional Food Source – a Review

Autor: Villarruel-López Angélica, Ascencio Felipe, Nuño Karla

Publikováno v: Polish Journal of Food and Nutrition Sciences, Vol 67, Iss 4, Pp 251-264 (2017)

Microalgae are a group of microorganisms used in aquaculture. The number of studies regarding their use as a functional food has recently increased due to their nutritional and bioactive compounds such as polysaccharides, fatty acids, bioactive pepti

Externí odkaz: https://doaj.org/article/0e20dda8613640dbae062b343522b63e

Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia.

Autor: Nuno KA; Cancer Biology Graduate Program, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.; These authors contributed to this work equally., Azizi A; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.; University of California Irvine School of Medicine, Irvine, California.; These authors contributed to this work equally., Köhnke T; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA., Lareau CA; Department of Pathology, Stanford University, Stanford, CA, USA.; Program in Immunology, Stanford University, Stanford, CA, USA., Ediwirickrema A; Cancer Biology Graduate Program, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA., Ryan Corces M; Cancer Biology Graduate Program, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.; Gladstone Institute of Neurological Disease, San Francisco, California.; Gladstone Institute of Data Science and Biotechnology, San Francisco, California.; Department of Neurology, University of California San Francisco, San Francisco, California., Satpathy AT; Department of Pathology, Stanford University, Stanford, CA, USA.; Program in Immunology, Stanford University, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Majeti R; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Oct 10. Date of Electronic Publication: 2023 Oct 10.

Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy.

Autor: Linde MH; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Fan AC; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Köhnke T; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Trotman-Grant AC; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Gurev SF; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Phan P; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Zhao F; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Haddock NL; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California., Nuno KA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Gars EJ; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California.; Department of Pathology, Stanford University, Stanford, California., Stafford M; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Marshall PL; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California., Dove CG; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Linde IL; Immunology Graduate Program, Stanford University School of Medicine, Stanford, California.; Department of Pathology, Stanford University, Stanford, California., Landberg N; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Miller LP; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Majzner RG; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Zhang TY; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California., Majeti R; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California.

Publikováno v: Cancer discovery [Cancer Discov] 2023 May 04; Vol. 13 (5), pp. 1164-1185.